Symptoms of menopause—global prevalence, physiology and implications

P Monteleone, G Mascagni, A Giannini… - Nature Reviews …, 2018 - nature.com
The symptoms of menopause can be distressing, particularly as they occur at a time when
women have important roles in society, within the family and at the workplace. Hormonal …

Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management

J Gandhi, A Chen, G Dagur, Y Suh, N Smith… - American journal of …, 2016 - Elsevier
Genitourinary syndrome of menopause, a new term for a condition more renowned as
atrophic vaginitis, is a hypoestrogenic condition with external genital, urological, and sexual …

2016 IMS Recommendations on women's midlife health and menopause hormone therapy

RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North …

DJ Portman, MLS Gass - The journal of sexual medicine, 2014 - academic.oup.com
Introduction The terminology for the genitourinary tract symptoms related to menopause was
vulvovaginal atrophy, which does not accurately describe the symptoms nor is a term that …

Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)

RE Nappi, L Cucinella, S Martella, M Rossi, L Tiranini… - Maturitas, 2016 - Elsevier
Female sexual dysfunction (FSD) and quality of life (QOL) are both multidimensional and
have a bidirectional relationship across the reproductive life span and beyond …

A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study

S Salvatore, RE Nappi, N Zerbinati, A Calligaro… - …, 2014 - Taylor & Francis
Objective This pilot study aimed to assess the efficacy and feasibility of fractional CO2 laser
in the treatment of vulvovaginal atrophy (VVA) in postmenopausal women. Methods VVA …

Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women

RE Nappi, E Martini, L Cucinella, S Martella… - Frontiers in …, 2019 - frontiersin.org
Vaginal health is an essential component of active and healthy aging in women at midlife
and beyond. As a consequence of hormonal deprivation and senescence, the anatomy and …

Estrogens and phytoestrogens in body functions

I Ceccarelli, L Bioletti, S Peparini, E Solomita… - Neuroscience & …, 2022 - Elsevier
Estrogens are the hormones of reproduction in women as well as of many other important
functions in the male and female body. They undergo significant changes in the different …

Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy

S Salvatore, RE Nappi, M Parma, R Chionna… - …, 2015 - Taylor & Francis
Objective To investigate the effects of fractional microablative CO2 laser on sexual function
and overall satisfaction with sexual life in postmenopausal women with vulvovaginal atrophy …

Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey

RE Nappi, S Palacios, N Panay, M Particco… - …, 2016 - Taylor & Francis
Objectives The aim of the European REVIVE survey was to achieve a better understanding
of vulvovaginal atrophy (VVA), a chronic and progressive condition after menopause. We …